Review: taking Amaryl and Losartan potassium together


Summary

Drug interactions are reported among people who take Amaryl and Losartan potassium together. This review analyzes the effectiveness and drug interactions between Amaryl and Losartan potassium. It is created by eHealthMe based on reports of 1,217 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Amaryl and Losartan potassium >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Amaryl

Amaryl has active ingredients of glimepiride. It is often used in diabetes. (latest outcomes from Amaryl 22,722 users)

Losartan Potassium

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. (latest outcomes from Losartan potassium 13,297 users)

On Aug, 25, 2016

1,217 people who take Amaryl, Losartan Potassium are studied.


Number of reports submitted per year:

Amaryl and Losartan potassium drug interactions.

Drug effectiveness over time:

Amaryl:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 42.0% - (3 of 7 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 50.0% - (2 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Losartan Potassium:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 57.0% - (4 of 7 people)
  • 5 - 10 years: 20.0% - (1 of 5 people)
  • 10+ years: 25.0% - (1 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Amaryl:
  • female: 55.0% - (5 of 9 people)
  • male: 46.0% - (6 of 13 people)
Losartan Potassium:
  • female: 36.0% - (4 of 11 people)
  • male: 16.0% - (2 of 12 people)

Drug effectiveness by age:

Amaryl:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (2 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 42.0% - (3 of 7 people)
  • 60+: 50.0% - (6 of 12 people)
Losartan Potassium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 50.0% - (3 of 6 people)
  • 60+: 21.0% - (3 of 14 people)

Most common drug interactions over time *:

< 1 month:
  • neutropenia
  • blood creatine phosphokinase increased
  • hyponatraemia
  • overdose
  • pollakiuria
  • polyuria
  • blood lactate dehydrogenase increased
  • cardiac death
  • contusion
  • glycosylated haemoglobin increased
1 - 6 months:
  • neutropenia
  • overdose
  • arthralgia
  • cardiac failure
  • decubitus ulcer
  • diabetes mellitus
  • eczema
  • hypotension
  • joint swelling
  • myocardial infarction
6 - 12 months:
  • blood creatine phosphokinase increased
  • hyponatraemia
  • anemia - hemolytic
  • decreased appetite
  • heart murmurs and other sounds
  • hypertension - essential
  • hypoglycaemia
  • neutropenia
  • overdose
  • pneumonia
1 - 2 years:
  • fall
  • abscess limb
  • breast mass
  • cellulitis
  • cholelithiasis
  • dyspnoea
  • hepatomegaly
  • hot flush
  • hypoaesthesia
  • hypoglycaemia
2 - 5 years:
  • gastrointestinal haemorrhage
  • death
  • cardiac arrest
  • cerebrovascular accident
  • chest pain
  • fluid overload
  • fluid retention
  • heart injury
  • hepatic failure
  • liver injury
5 - 10 years:
  • hypoglycaemia
  • bad breath
  • cholestatic liver injury
  • hyperammonaemia
  • hyperkalaemia
  • lactic acidosis
  • nausea
  • renal failure
  • senile dementia
  • vomiting
10+ years:
  • blood urine present
  • urinary incontinence
  • daydreaming
  • delirium
  • dizziness
  • erection problems
  • hyperkalaemia
  • insomnia
  • lethargy
  • nausea
not specified:
  • nausea
  • blood glucose increased
  • dyspnoea
  • myocardial infarction
  • diarrhoea
  • chest pain
  • weight decreased
  • oedema peripheral
  • cardiac failure congestive
  • hypertension

Most common drug interactions by gender *:

female:
  • nausea
  • blood glucose increased
  • diarrhoea
  • dyspnoea
  • arthralgia
  • vomiting
  • oedema peripheral
  • chest pain
  • fall
  • fatigue
male:
  • myocardial infarction
  • nausea
  • blood glucose increased
  • weight decreased
  • dizziness
  • dyspnoea
  • cardiac failure congestive
  • hypertension
  • asthenia
  • chest pain

Most common drug interactions by age *:

20-29:
  • arthralgia
  • blood pressure increased
  • complex partial seizures
  • herpes simplex
  • hyperphosphataemia
  • hypocalcaemia
  • muscle spasms
  • nausea
  • pneumonia
  • vomiting
30-39:
  • oedema peripheral
  • myocardial infarction
  • cardiac failure congestive
  • cough
  • crohn's disease
  • dehydration
  • jejunitis
  • pain in limb
  • paraesthesia
  • rectal haemorrhage
40-49:
  • oedema peripheral
  • myocardial infarction
  • nausea
  • weight increased
  • cardiac disorder
  • fall
  • pneumonia
  • abdominal pain upper
  • arthralgia
  • back pain
50-59:
  • arthralgia
  • myocardial infarction
  • diarrhoea
  • chest pain
  • nausea
  • pancreatitis
  • cardiac arrest
  • coronary artery disease
  • hyperkalaemia
  • abdominal pain
60+:
  • nausea
  • blood glucose increased
  • dyspnoea
  • weight decreased
  • dizziness
  • myocardial infarction
  • asthenia
  • chest pain
  • diarrhoea
  • hypertension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Amaryl and Losartan potassium?

Can you answer these questions?

More questions for: Amaryl, Losartan potassium

You may be interested in these reviews

More reviews for: Amaryl, Losartan potassium

On eHealthMe, Amaryl (glimepiride) is often used to treat diabetes. Losartan potassium (losartan potassium) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.